查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2126687

蔗糖鐵市場：按應用、最終用戶、分銷管道和地區分類。

Iron Sucrose Market, By Application, By End User, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年，蔗糖鐵市場價值將達到 4.197 億美元，到 2033 年將達到 7.964 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 9.6%。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 4.197億美元
歷史數據時期： 2020年至2024年 預測期： 2026-2033
2026年至2033年預測期間的複合年成長率： 9.60% 2033年市場規模預測： 7.964億美元

蔗糖鐵是一種廣泛使用的靜脈注射，建議用於治療慢性腎臟病（CKD）患者、接受血液透析的患者以及對口服鐵劑不耐受或無反應的患者的缺鐵性貧血（IDA）。蔗糖鐵中含有的多核氫​​氧化鐵(III)-蔗糖複合物能夠持續釋放元素鐵，促進快速補充鐵質和紅血球生成。

市場動態

全球蔗糖鐵市場成長的主要促進因素包括：缺鐵性貧血盛行率不斷上升、慢性腎臟病病患者和透析患者靜脈鐵劑治療的日益普及，以及臨床實踐中腸外鐵劑製劑接受度的提高。此外，開發中國家醫療保健服務的改善、非專利藥監管管道的便利性以及臨床指南推薦在特定患者群體中使用靜脈鐵劑治療，也是推動蔗糖鐵市場成長的關鍵因素。

然而，市場面臨許多限制因素，包括過敏反應和鐵過載的風險、需要監督給藥，以及來自新型靜脈鐵劑（可進行高劑量或單次輸注治療）的競爭。儘管如此，亞太地區（尤其是中國和印度）慢性腎臟病盛行率的上升以及醫療保健服務的改善，將為蔗糖鐵市場的成長帶來可觀的機會。此外，手術全期貧血和心臟衰竭相關缺鐵的研究不斷深入，也可能進一步推動蔗糖鐵的治療應用。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球蔗糖鐵市場主要參與者的概況：公司亮點、產品系列、主要特徵、財務表現和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球蔗糖鐵市場報告」旨在為產業內的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球蔗糖鐵市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章：市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 市場機遇
  • 監管趨勢
  • 產業趨勢

第4章 全球蔗糖鐵市場：依應用領域分類，2021-2033年

  • 慢性腎臟病
  • 非慢性腎臟病
  • 其他

第5章 全球蔗糖鐵市場：依最終用戶分類，2021-2033年

  • 醫院
  • 透析中心
  • 專科診所
  • 其他

第6章 全球蔗糖鐵市場：依通路分類，2021-2033年

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第7章 全球蔗糖鐵市場：依地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • 公司簡介
    • CSL Limited
    • Fresenius Kabi AG
    • Viatris Inc.
    • Hikma Pharmaceuticals PLC
    • Sandoz
    • Reddy's Laboratories Limited
    • Lupin Limited
    • Emcure Pharmaceuticals Limited
    • Gland Pharma Limited
    • Zydus Lifesciences Limited

第9章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI9968

Iron Sucrose Market is estimated to be valued at USD 419.7 Mn in 2026 and is expected to reach USD 796.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 419.7 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.60% 2033 Value Projection: USD 796.4 Mn

Iron sucrose is an intravenous iron formulation that is widely used and is recommended for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), patients on hemodialysis, and patients who are intolerant or have non-responsiveness to oral iron therapy. The polynuclear iron (III)-hydroxide sucrose complex in iron sucrose is suitable for controlled release of elemental iron and helps to replenish iron rapidly and erythropoiesis.

Market Dynamics

The global iron sucrose market is driven by increasing prevalence of iron deficiency anemia, increasing use of intravenous iron therapy in chronic kidney disease and dialysis patients, and increasing acceptance of parenteral iron in clinical practice. Some of the key driving factors for the growth of the iron sucrose market are improving access to healthcare in developing economies, favorable regulatory pathway for generic formulations, and clinical guidelines recommending intravenous iron in appropriate patient populations.

However, a number of constraints are present in the market, such as risk of hypersensitivity, iron overload, and need for supervised administration, and competition from newer formulations of intravenous iron with high-dose or single-infusion treatment. Nevertheless, increasing prevalence of chronic kidney disease and access to healthcare in the Asia-Pacific region, especially in China and India, will offer lucrative opportunities for the growth of the iron sucrose market. In addition, increasing research in the area of perioperative anemia and iron deficiency associated with heart failure may drive the therapeutic use of iron sucrose.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global iron sucrose market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include CSL Limited, Fresenius Kabi AG, Viatris Inc., Hikma Pharmaceuticals PLC, Sandoz, Dr. Reddy's Laboratories Limited, Lupin Limited, Emcure Pharmaceuticals Limited, Gland Pharma Limited, and Zydus Lifesciences Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global iron sucrose market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global iron sucrose market

Market Segmentation

  • Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Chronic Kidney Disease
  • Non-Chronic Kidney Disease
  • Others
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Dialysis Centers
  • Specialty Clinics
  • Others
  • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • CSL Limited
  • Fresenius Kabi AG
  • Viatris Inc.
  • Hikma Pharmaceuticals PLC
  • Sandoz
  • Reddy's Laboratories Limited
  • Lupin Limited
  • Emcure Pharmaceuticals Limited
  • Gland Pharma Limited
  • Zydus Lifesciences Limited

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Iron Sucrose Market, By Application
    • Global Iron Sucrose Market, By End User
    • Global Iron Sucrose Market, By Distribution Channel
    • Global Iron Sucrose Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Global Iron Sucrose Market, By Application, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Chronic Kidney Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Non-Chronic Kidney Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Iron Sucrose Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Dialysis Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Iron Sucrose Market, By Distribution Channel, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Iron Sucrose Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Company Profile
    • CSL Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Fresenius Kabi AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Viatris Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Hikma Pharmaceuticals PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sandoz
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Reddy's Laboratories Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Lupin Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Emcure Pharmaceuticals Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Gland Pharma Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Zydus Lifesciences Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us